triethylenephosphoramide has been researched along with cytarabine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abendroth, K; Siering, VH | 1 |
| Chamberlain, MC | 1 |
1 review(s) available for triethylenephosphoramide and cytarabine
| Article | Year |
|---|---|
[Principles of the effect of cytostatics].
Topics: Antineoplastic Agents; Asparaginase; Cell Division; Chlorambucil; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Fluorouracil; Folic Acid Antagonists; Humans; Melphalan; Mercaptopurine; Methotrexate; Neoplasms; Triaziquone; Triethylenephosphoramide; Vincristine | 1974 |
1 other study(ies) available for triethylenephosphoramide and cytarabine
| Article | Year |
|---|---|
Combined-modality treatment of leptomeningeal gliomatosis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Cohort Studies; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Disease Progression; Female; Follow-Up Studies; Glioblastoma; Humans; Male; Meningeal Neoplasms; Methotrexate; Middle Aged; Radiotherapy, Adjuvant; Survival Rate; Treatment Outcome; Triethylenephosphoramide | 2003 |